Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ: SDGR )

21.93 -0.84 (-3.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
4 Analysts Have This to Say About Schrodinger
Via Benzinga
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
Mabwell Biosciences out-licensed global rights for a rare disease drug to Disc Medicine of Cambridge, MA in a $412.5 million agreement. Mabwell will receive $10 million upfront, $402.5 million in... 
Via Talk Markets
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities
From Schrödinger, Inc.
Via Business Wire
Why These 7 Healthcare Stocks Could Soar in 2023
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023. 
Via InvestorPlace
7 Drug Stocks That Will Soar in 2023
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
Via InvestorPlace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting
From Schrödinger
Via Business Wire
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 49 companies made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference
From Schrödinger
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference
From Schrödinger
Via Business Wire
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
3 Hypergrowth Stocks That Will Make You a Millionaire by 2027
These companies' great third-quarter results, along with their very promising technologies, are likely to turn them into hypergrowth stocks. 
Via InvestorPlace
Schrödinger Reports Third Quarter 2022 Financial Results
From Schrödinger, Inc.
Via Business Wire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 236 companies set new 52-week lows. 
Via Benzinga
Schrödinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Announce Third Quarter 2022 Financial Results on November 3
From Schrödinger
Via Business Wire
Schrödinger Hosts Platform Day
From Schrödinger
Via Business Wire
Schrödinger to Host Platform Day on October 6, 2022
From Schrödinger, Inc.
Via Business Wire
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
7 Small-Cap Stock Picks to Beat the September Market Slump
With the macro environment not as dreary as the bears believe, investors should consider buying one or more of my small-cap stock picks. 
Via InvestorPlace
Schrödinger to Present at Citi’s 17th Annual BioPharma Conference
From Schrödinger, Inc.
Via Business Wire
Cathie Wood Loads Up $4.6M In Bill Gates-Backed Healthcare Tech Company
Cathie Wood-led Ark Investment Management on Thursday bought 162,276 shares of Schrodinger Inc (NASDAQ: SDGR) through the Ark Genomic Revolution ETF (BATS: ARKG), trading d 
Via Benzinga
Schrödinger Reports Inducement Grants To Newly Appointed Chief Financial Officer
From Schrödinger, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.